Nalaganje...
Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer
The dependency of prostate cancer (PCa) growth on androgen receptor (AR) signaling has been harnessed to develop first-line therapies for high-risk localized and metastatic PCa treatment. However, the occurrence of aberrant expression, mutated or splice variants of AR confers resistance to androgen...
Shranjeno v:
| izdano v: | Cancer Lett |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7370677/ https://ncbi.nlm.nih.gov/pubmed/32485222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2020.05.027 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|